False-positive phencyclidine immunoassay results caused by 3,4-methylenedioxypyrovalerone (MDPV)

Drug Testing and Analysis

Volumn 5, Issue 2, 2013, Pages 130-132

  Macher, Abe M ^a   Penders, Thomas M ^b  

^a U S PUBLIC HEALTH SERVICE   (United States)

^b EAST CAROLINA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FALSE POSITIVE;

3,4 METHYLENEDIOXYPYROVALERONE; DEXTROMETHORPHAN; DIPHENHYDRAMINE; DOXYLAMINE; IBUPROFEN; IMIPRAMINE; KETAMINE; MESORIDAZINE; PHENCYCLIDINE; PSYCHOTROPIC AGENT; THIORIDAZINE; TRAMADOL; UNCLASSIFIED DRUG; VENLAFAXINE;

BLOOD LEVEL; DRUG ABUSE; FALSE POSITIVE RESULT; HUMAN; HYPERTHERMIA; IMMUNOASSAY; LABORATORY TEST; LETTER; LIQUID CHROMATOGRAPHY; MASS FRAGMENTOGRAPHY; NEUROTOXICITY; PRIORITY JOURNAL; SCREENING; TANDEM MASS SPECTROMETRY; TOXICOLOGICAL PARAMETERS;

EID: 84873746492     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.1371     Document Type: Letter

References (20)

1. C. Bell, C. George, A. T. Kicman, A. Traynor . Development of a rapid LC-MS/MS method for direct urinalysis of designer drugs. Drug Test. Anal. 2011, 3, 496.
2. J. C. Yohannan, J. S. Bozenko . The characterization of 3, 4-methylenedioxypyrovalerone (MDPV). Microgram J. 2010, 7, 12.
3. S. D. Brandt, S. Freeman, H. R. Sumnall, F. Measham, J. Cole . Analysis of NRG 'legal highs' in the UK: Identification and formation of novel cathinones. Drug Test. Anal. 2011, 3, 569.
4. B. L. Murray, C. M. Murphy, M. C. Beuhler . Death following recreational use of designer drug 'Bath Salts' containing 3, 4-methylenedioxypyrovalerone (MDPV). J. Med. Toxicol. 2012, 8, 69.
5. J. Mugele, K. A. Nanagas, L. M. Tormoehlen . Serotonin syndrome associated with MDPV use: A case report. Ann. Emerg. Med. 2012 January 9, Epub ahead of print. Available at: http://www.ncbi.nlm.nih.gov/pubmed?term="Annals+of+emergency+medicine"[jour]+AND+Mugele+J[first+author]&cmd=detailssearch [12 May 2012].
6. H. A. Borek, C. P. Holstege . Hyperthermia and multi-organ failure after abuse of "Bath Salts" containing 3, 4-methylenedioxypyrovalerone. Ann. Emerg. Med. 2012 March 2, Epub ahead of print Available at: http://www.ncbi.nlm.nih.gov/pubmed?term=Annals+of+emergency+medicine [jour]+AND+Borek+HA[first+author]&cmd=detailssearch [12 May 2012].
7. Beckman Coulter SYNCHRON System Chemistry Information Sheet, Phencyclidine (PCP). REF 475009, Chemistry Information Sheet A18537 AF. Beckman Coulter Inc, Fullerton, CA, 92835. August 2010.
8. T. M. Penders, R. Gestring . Hallucinatory delirium following use of MDPV: 'Bath Salts'. Gen. Hosp. Psychiatr. 2011, 33, 525.
9. A. Macher . Drug abuse: Methylenedioxypyrovalerone (MDPV) and toxic psychosis. American Jails 2011, 25, 63.
10. M. Coppola, R. Mondola . 3, 4-methylenedioxypyrovalerone (MDPV): Chemistry, pharmacology and toxicology of a new designer drug of abuse marketed online. Toxicol. Lett. 2012, 208, 12.
11. European Monitoring Centre for Drugs and Drug Addiction. Drug profiles: Synthetic cathinones. Available at: http://www.emcdda.europa.eu/publications/drug-profiles/synthetic-cathinones [2 April 2012].
12. P. C. Meltzer, D. Butler, R. Deschamps, B. K. Madras . 1-(4-methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (pyrovalerone) analogues: A promising class of monoamine uptake inhibitors. J. Med. Chem. 2006, 49, 1420.
13. E. Alexy, L. M. Labay, J. Corvo . Bio-analytical quantification of MDPV: A paranoia inducing designer stimulant. Poster P 082, Joint Meeting of the Society of Forensic Toxicologists & the International Association of Forensic Toxicologists, San Francisco, CA, September 25-30, 2011.
14. Drug Enforcement Administration. Department of Justice. Schedules of controlled substances: Temporary placement of three synthetic cathinones in Schedule 1. Final order. F. R. 2011, 76, 65371.
15. D. P. Kasick, C. A. McKnight, E. Klisovic . 'Bath Salt' ingestion leading to severe intoxication delirium: Two cases and a brief review of the emergence of mephedrone use. Am. J. Drug Alcohol Ab. 2012, 38, 176.
16. B. T. Ly, S. L. Thornton, C. Buono, J. A. Stone, A. H. Wu . False-positive urine phencyclidine immunoassay screen result caused by interference by tramadol and its metabolites. Ann. Emerg. Med. 2011, Sept 14, Epub ahead of print. Available at:http://www.ncbi.nlm.nih.gov/pubmed/21924518. [12 May 2012].
17. K. E. Moeller, K. C. Lee, J. C. Kissack . Urine drug screening: Practical guide for clinicians. Mayo Clin. Proc. 2008, 83, 66.
18. S. F. Sena, S. Kazimi, A. H. B. Wu . False-positive phencyclidine immunoassay results caused by venlafaxine and O-desmethylvenlafaxine. Clin. Chem. 2002, 48, 676.
19. S. Strano-Rossi, A. B. Cadwallader, X. de la Torre, F. Boltre . Toxicological determinatioin and in vitro metabolism of the designer drug methylenedioxypyrovalerone (MDPV) by gas chromatography/mass spectrometry and liquid chromatography/quadrupole time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 2010, 24, 2706.
20. M. R. Meyer, P. Du, F. Schuster, H. H. Maurer . Studies on the metabolism of the alpha-pyrrolidinophenone designer drug methylenedioxy-pyrovalerone (MDPV) in rat and human urine and human liver microsomes using GC/MS. J. Mass Spectrom. 2010, 45, 1426.